Showing 2041-2050 of 8830 results for "".
EXELO2 by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/exelo2-by-quantel-derma/19448/EXELO2 by Quantel Derma is a versatile laser system for fractional treatments and full ablation for the treatment of wrinkles and scars. Shape and size of the treatment area can be set directly at the scanner hand-piece. EXCELO2 offers Random Scanning for better aesthetic results and Full Ablation MKelly on CoolSculpting
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/kelly-on-coolsculpting/19462/Watch to hear Kelly discuss results of the CoolSculpting procedure he had done to his abdomen.Sciton Resurfacing Laser Technologies - Patient Testimonials
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sciton-resurfacing-laser-technologies-patient-testimonials--michisug/19484/Sciton Laser Technology treatments include Deep Resurfacing, MicroLaserPeel, ProFractional Therapy, and Combination Treatments to stimulate collagen, correct superficial imperfections almost immediately, and improve skin's texture & tone in just 1-4 treatment sessions.Dermatology and CTCL: Recommendations
https://practicaldermatology.com/series/dermwire-tv/dermatology-and-ctcl-recommendations/26798/Larisa J. Geskin, MD, Professor of Dermatology at Columbia University Medical Center, discusses "Time to Act: A Global Patient-Focused Consensus for Improving Care in Cutaneous T-Cell Lymphoma (CTCL)," a global consensus statement from Kyowa Kirin that recommends, among other things, that dermatologDermWire TV Extra: Dr. Ruiz on GEP Testing for SCC
https://practicaldermatology.com/topics/skin-of-color/dermwire-tv-extra-dr-ruiz-gep-testing-scc/29497/Emily Ruiz, MD, MPH, FAAD, a Mohs surgeon at Brigham and Women's Hospital and cutaneous oncologist at Dana-Farber Cancer Institute, discusses her recent Future Oncology article, "Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profile."Psoriasis Update: Current State, Pipeline, and More
https://practicaldermatology.com/issues/july-2025/psoriasis-update-current-state-pipeline-and-more/36509/April W. Armstrong, MD, MPH, has been a driving force behind advancements in psoriasis treatments in recent years. A professor and chief of dermatology at University of California Los Angeles, Dr. Armstrong has served in leadership positions for the National Psoriasis Foundation, International PsoriFighting for Coverage: Combatting Private Insurance to Get Patients the Drugs They Need
https://practicaldermatology.com/issues/july-2025/fighting-for-coverage/36503/Aside from decreasing reimbursement rates, obtaining prior authorization from private insurance for medications that our patients desperately need to improve their lives, improve their skin conditions, and improve their wellbeing is probably the greatest challenge that dermatologists face today.Telephone Mystery Shopping and Converting New Patients
https://practicaldermatology.com/issues/april-2025/telephone-mystery-shopping-and-converting-new-patients/35621/Even with today’s market focused on online digital marketing, a practice’s biggest revenue source opportunity still seems to be the phones. The first interaction most new patients have with a practice is on the phone, which used to be about 99% of the time; now, we believe it is about 80%.Emrosi Launched in the US for Rosacea
https://practicaldermatology.com/series/dermwire-tv/emrosi-launched-in-the-us-for-rosacea/33943/In this week's DermwireTV, a new treatment for rosacea is launched in the US; long-term data is presented for tapinarof 1% cream for atopic dermatitis; and in our C-Suite Chats segment, we speak with the CEO and Co-Founder of Mama Sol.I Came In Like a Wrecking Ball
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/i-came-in-like-a-wrecking-ball/33162/I have to start by warning you, dear reader, that I am writing my first editorial for Practical Dermatology immediately after typing up four appeal letters to insurance companies.